BiotechTube

Magnevist + Dotarem + Gadovist

Pre-clinicalCompleted
0 watching 0 views this week💤 Quiet
15
Hype Score

Development Stage

1
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Magnetic Resonance Imaging Contrast Agents

Conditions

Magnetic Resonance Imaging Contrast Agents

Trial Timeline

Jul 1, 1990 → Apr 1, 2019

NCT ID
NCT03910114

About Magnevist + Dotarem + Gadovist

Magnevist + Dotarem + Gadovist is a pre-clinical stage product being developed by Guerbet for Magnetic Resonance Imaging Contrast Agents. The current trial status is completed. This product is registered under clinical trial identifier NCT03910114. Target conditions include Magnetic Resonance Imaging Contrast Agents.

Hype Score Breakdown

Clinical
5
Activity
2
Company
2
Novelty
2
Community
1

Clinical Trials (1)

NCT IDPhaseStatus
NCT03910114Pre-clinicalCompleted

Competing Products

20 competing products in Magnetic Resonance Imaging Contrast Agents

See all competitors
ProductCompanyStageHype Score
HRS-9231 + GadobutrolJiangsu Hengrui MedicinePhase 2
52
D1000078 + D1000082 + D1000083 + D1000085AstraZenecaPhase 1
33
Gadobutrol (Gadavist/Gadovist, BAY86-4875)BayerPre-clinical
20
Gadobutrol (Gadovist, BAY86-4875) + Gadopentetate Dimeglumine (Magnevist, BAY86-4882)BayerPhase 3
74
Gadoquatrane (BAY1747846)BayerPhase 3
74
Gadopentetate dimeglumine (Magnevist, BAY86-4882, SH L 451A) + Gadopentetate dimeglumine (Magnevist, BAY86-4882, SH L 451A)BayerPhase 2
49
GBCAsBayerPre-clinical
20
Gadobutrol (Gadovist, BAY86-4875)BayerPhase 3
74
BAY1747846BayerPhase 1
30
Gadoterate (Dotarem/Clariscan) + Gadobutrol (Gadavist/Gadovist, BAY86-4875)BayerApproved
82
Gadoquatrane (BAY1747846) + Gadobutrol + Gadoterate meglumine + GadoteridolBayerPhase 3
74
Gadobutrol (Gadovist, BAY86-4875)BayerPre-clinical
20
Gadopentetate dimeglumine (Magnevist, BAY86-6661)BayerPhase 3
74
Gadoquatrane (BAY1747846) + Gadobutrol + Gadoterate meglumine + GadoteridolBayerPhase 3
74
Gadobutrol (Gadavist, Gadovist, BAY86-4875)BayerPhase 1
30
Gadobutrol (Gadovist, BAY86-4875)BayerPre-clinical
20
Gadobutrol (Gadavist, BAY86-4875)BayerPhase 1
30
BAY1747846 + Matching placeboBayerPhase 1
30
Gadoquatrane (BAY1747846) 0.03 mmol Gd/kg + Gadoquatrane (BAY1747846) 0.1 mmol Gd/kg + Matching placeboBayerPhase 1
30
Gadobutrol (Gadavist/Gadovist, BAY86-4875)BayerPre-clinical
20

Other Products from Guerbet

DOTAREMApproved
77
Dotarem®-enhanced MRIApproved
77
Xenetix + VisipaqueApproved
77
Dotarem + GadovistApproved
77
Ioversol 320 mgI/mL + Iodixanol 320 mgI/mLApproved
77